HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kenichiro Kitamura Selected Research

camostat

8/2021A serine protease inhibitor camostat mesilate prevents podocyte apoptosis and attenuates podocyte injury in metabolic syndrome model rats.
12/2016Pharmacological and genetic reappraisals of protease and oxidative stress pathways in a mouse model of obstructive lung diseases.
10/2016A serine protease inhibitor attenuates aldosterone-induced kidney injuries via the suppression of plasmin activity.
2/2016Combination therapy with renin-angiotensin-aldosterone system inhibitor telmisartan and serine protease inhibitor camostat mesilate provides further renoprotection in a rat chronic kidney disease model.
1/2015The serine protease inhibitor camostat mesilate attenuates the progression of chronic kidney disease through its antioxidant effects.
7/2013The antifibrotic effect of a serine protease inhibitor in the kidney.
1/2009Camostat mesilate inhibits prostasin activity and reduces blood pressure and renal injury in salt-sensitive hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kenichiro Kitamura Research Topics

Disease

10Hypertension (High Blood Pressure)
08/2021 - 01/2005
8Fibrosis (Cirrhosis)
08/2019 - 12/2008
7Chronic Renal Insufficiency
10/2020 - 09/2011
5Chronic Kidney Failure (Chronic Renal Failure)
12/2012 - 07/2002
4Inflammation (Inflammations)
04/2020 - 03/2015
4Cardiovascular Diseases (Cardiovascular Disease)
01/2020 - 11/2010
3Proteinuria
08/2021 - 10/2012
3Wounds and Injuries (Trauma)
08/2021 - 07/2006
3Infections
11/2018 - 10/2014
3Anemia
10/2014 - 08/2004
2Atherosclerosis
10/2020 - 01/2017
2Diabetes Mellitus
10/2020 - 01/2019
2Acute Kidney Injury (Acute Renal Failure)
07/2020 - 11/2018
2Type 2 Diabetes Mellitus (MODY)
07/2020 - 01/2019
2Kidney Diseases (Kidney Disease)
08/2019 - 10/2016
2Hyperglycemia
01/2019 - 12/2005
2Hyperplasia
01/2019 - 07/2002
2Insulin Resistance
01/2019 - 03/2014
2Ureteral Obstruction
10/2016 - 07/2013
2Renal Insufficiency (Renal Failure)
12/2012 - 07/2007
2Hypertrophy
10/2012 - 07/2002
2Renal hypouricemia
10/2008 - 04/2005
1Metabolic Syndrome (Dysmetabolic Syndrome X)
08/2021
1Rodent Diseases
08/2021
1Esophageal Squamous Cell Carcinoma
10/2020
1Colorectal Neoplasms (Colorectal Cancer)
10/2020
1Acute Coronary Syndrome
08/2020
1Transient Ischemic Attack
08/2020
1Hemolysis
07/2020
1Weight Loss (Weight Reduction)
07/2020
1Ulcerative Colitis
04/2020
1Colitis
04/2020
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
04/2020
1Crohn Disease (Crohn's Disease)
04/2020
1Ovarian Cysts (Ovarian Cyst)
02/2020
1Pituitary Neoplasms (Pituitary Adenoma)
02/2020
1Thyroiditis
02/2020
1Thyrotoxicosis
02/2020
1Neck Pain (Cervicalgia)
02/2020
1Premature Aging
01/2020
1Peripheral Arterial Disease
01/2019
1Vascular Remodeling
01/2019
1Rupture
01/2019
1Diabetic Nephropathies (Diabetic Nephropathy)
01/2019

Drug/Important Bio-Agent (IBA)

10Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA
08/2021 - 01/2003
8Proteins (Proteins, Gene)FDA Link
10/2020 - 02/2002
7camostatIBA
08/2021 - 01/2009
7SaltsIBA
01/2018 - 01/2005
5SodiumIBA
04/2020 - 01/2003
5prostasinIBA
04/2020 - 02/2002
5Uric Acid (Urate)IBA
01/2011 - 12/2003
4AntioxidantsIBA
01/2018 - 09/2011
4Epithelial Sodium ChannelsIBA
06/2013 - 01/2005
3Serine Proteases (Serine Protease)IBA
08/2021 - 03/2014
3Anti-Bacterial Agents (Antibiotics)IBA
04/2020 - 07/2006
3AldosteroneIBA
10/2016 - 02/2002
3AdenineFDA LinkGeneric
02/2016 - 12/2012
3Messenger RNA (mRNA)IBA
01/2015 - 02/2002
3IronIBA
10/2014 - 08/2004
2AntibodiesIBA
10/2020 - 02/2020
2Complementary DNA (cDNA)IBA
10/2020 - 01/2014
2Ferritins (Ferritin)IBA
01/2020 - 10/2014
2Angiopoietin-Like Protein 2IBA
01/2019 - 02/2016
2Angiotensin IIIBA
01/2018 - 06/2013
2LigandsIBA
01/2017 - 01/2014
2Transforming Growth Factors (Transforming Growth Factor)IBA
02/2016 - 07/2013
2CreatinineIBA
01/2016 - 10/2012
2Prednisolone (Predate)FDA LinkGeneric
03/2015 - 01/2009
2CollagenIBA
07/2013 - 10/2012
2AngiotensinsIBA
06/2013 - 01/2012
2Antihypertensive Agents (Antihypertensives)IBA
02/2012 - 01/2009
2urate transporterIBA
01/2011 - 04/2005
2Amiloride (Midamor)FDA LinkGeneric
08/2009 - 01/2005
1Immunoglobulin G (IgG)IBA
10/2020
1AntigensIBA
10/2020
1Peptides (Polypeptides)IBA
10/2020
1ImmunosorbentsIBA
10/2020
1Biomarkers (Surrogate Marker)IBA
08/2020
1Glycerol (Glycerine)FDA LinkGeneric
07/2020
1HaptoglobinsIBA
07/2020
1Dextrans (Dextran)FDA Link
04/2020
1sodium sulfate (sodium bisulfate)FDA LinkGeneric
04/2020
1anti-thyroglobulinIBA
02/2020
1thyrotropin-binding inhibitory immunoglobulinIBA
02/2020
1Estradiol (Delestrogen)FDA LinkGeneric
02/2020
1Follicle Stimulating Hormone (Follitropin)FDA Link
02/2020
1Iodide Peroxidase (Deiodinase)IBA
02/2020
1Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
02/2020
1Transferrin (beta 2 Transferrin)IBA
01/2020
1Blood Coagulation Factors (Coagulation Factor)IBA
08/2019
1edoxabanIBA
08/2019
1Sodium-Glucose Transporter 2 InhibitorsIBA
01/2019
1Epithelial Cell Adhesion MoleculeIBA
01/2019
1ApolipoproteinsIBA
01/2019
1Sodium-Glucose Transport ProteinsIBA
01/2019

Therapy/Procedure

7Renal Dialysis (Hemodialysis)
01/2020 - 08/2004
6Therapeutics
02/2016 - 07/2006
2Oral Administration
01/2018 - 07/2006
1Enema (Enemas)
07/2020
1Glycemic Control
07/2020